baber/WOPTO huggingface dataset:
Patent MX-2007006507-A (MX)
Title: Visible open indicator .
Inventor: STEPNIAK FRANK M
IPC: H01H33/00
Filed: 2007-05-31
Abstract: A visible open indicator for high voltage vacuum interrupters and switches, which use a vacuum bottle having a high voltage contact and an actuating element that opens and closes the contact, is provided. The visible open indicator includes: an actuating mechanism that operates the actuating element; a housing that contains the actuating mechanism; an indicator attached to the actuating mechanism, wherein the indicator shows that the contact is in an open position or closed position; a viewing window extending through the housing, wherein the viewing window is aligned with the indicator so that the indicator can be viewed through the viewing window. The indicator includes a first indicating portion and a second indicating portion.; The first indicating portion is visible through the viewing window when the contact is open and the second indicating portion is visible through the viewing window when the contact is closed.
Patent MX-2007006822-A (MX)
Title: Therapeutic formulations of keratinocyte growth factor.
Inventor: TREUHEIT MICHAEL J
IPC: A61K38/00
Filed: 2005-12-12
Abstract: The present invention provides long-term stable formulations of lyophilizedkeratinocyte growth factor and methods for making a lyophilized compositioncomprising keratinocyte growth factor.
Patent MX-2007006946-A (MX)
Title: A soy protein isolate and process for its manufacture.
Inventor: SHEN RICHARD
IPC: A23L11/00
Filed: 2005-12-16
Abstract: A soy protein isolate and method for preparing the same are disclosed. The novel soy protein isolate possesses excellent suspension stability and flavor. The process used to produce the soy protein isolate includes an enzyme hydrolysis process, and the resulting soy protein isolate can be used in acidic beverage formulations.
Patent MX-2007007690-A (MX)
Title: Shared electrode pattern field effect sensor and joystick therewith.
Inventor: KALIHER PAUL L
IPC: G06F3/038
Filed: 2005-12-22
Abstract: The present invention is directed to a shared electrode pattern field effect touch sensor apparatus. The apparatus includes first and second spaced electrode patterns, each having an inner electrode and an outer electrode. The inner electrode includes a primary portion defining a primary sense area and at least one secondary portion. Secondary portions of at least two patterns are adjacently disposed, and define secondary sense areas. A pulse generation circuit and a detection circuit are electrically coupled to each pattern. The presence of an object proximate a primary sense area activates one detection circuit. The presence of an object proximate a secondary sense area activates two detection circuits. A controller in communication with the detection circuits senses activation of the detection circuits. In a preferred embodiment, the apparatus is a navigational control device. A method of processing touch sensor field effect signals is also disclosed.
Patent MX-2007008289-A (MX)
Title: Oval cross-section tube, method for the production and device for the use thereof.
Inventor: THOMASSET JACQUES
IPC: B29D23/20
Filed: 2005-12-27
Abstract: The invention relates to an elastic substantially tubular package (1) for a semi-liquid or pasty extractable by a finger pressure product comprising a skirt (2), a head (3) and optionally a cap (4), wherein said skirt (2) is formed from a wound foil and is provided with a longitudinal weld seam (6) formed by the overlapping of the edges thereof and the head (3) is fixed to the circumference of the skirt end (7) and forms an oval cross-section at the level of the skirt (2) fixing area. The inventive package (1) is characterised in that the end of the longitudinal weld seam (6) contacting the head is located in or near an area where the radius of curvature of the oval cross-section is minimal.
Patent MX-2007009557-A (MX)
Title: Method and composition for treating mammalian diseases and injuries caused by the over-expression of peroxynitrite.
Inventor: MARTIN ALAIN
IPC: A61K31/195
Filed: 2006-02-10
Abstract: The present invention provides a method for treating wounds and diseases in mammals, caused by mammalian cells involved in an inflammatory response, by altering indigenous in vivo levels of peroxynitrous acid, and salts thereof. The method comprises contacting the mammalian cells with a therapeutically effective amount of a reactive oxygen species mediator, wherein the reactive oxygen species mediator is selected from the group consisting of pyruvates, pyruvate precursors, a- keto acids having four or more carbon atoms, precursors of ce-keto acids having four or more carbon atoms, and the salts thereof, wherein mediation of reactive oxygen species results in mediation of peroxynitrous acid. The present invention further provides a pharmaceutical composition for treating wounds and diseases in mammals, caused by mammalian cells involved in an inflammatory response, by altering indigenous in vivo levels of peroxynitrous acid, and salts thereof.
Patent MX-2007012563-A (MX)
Title: Systems and devices for delivering volatile materials having perfume components with a high kovat's index.
Inventor: LIU ZAIYOU
IPC: A01M1/20
Filed: 2006-04-11
Abstract: A volatile material delivery system for emitting or releasing volatile materials to the atmosphere is provided. More specifically, delivery systems for delivering one or more volatile materials having perfume components where at least about 40 weight percent of the perfume components have a Kovat's Index of 1500 or more, are also provided.
Patent MX-2007015303-A (MX)
Title: Erythropoietin receptor peptide formulations and uses.
Inventor: DULIEGE ANNE-MARIE
IPC: A61K38/17
Filed: 2006-06-05
Abstract: The present invention relates to peptide compounds that are agonists of the erythropoietin receptor (EPO-R). The invention also relates to therapeutic methods using such peptide compounds to treat disorders associated with insufficient or defective red blood cell production. Pharmaceutical compositions, which comprise the peptide compounds of the invention, and dosages are also provided.
Patent MX-2007016566-A (MX)
Title: Improvement to construction system with contact formworks.
Inventor: HOYOS FERNANDO JAVIER HUMPHREY
IPC: E04G13/00
Filed: 2007-12-19
Abstract: The invention relates to improvements in a construction system using contact formworks for dwellings and buildings. Said system comprises contact formworks made of different materials, which provide the concrete element with predetermined shapes involving deformations or spaces in the external or internal walls, and which enable an insulating material to be affixed to the structural element, where said insulating material is subsequently covered with finishing materials, such as drywall, thereby producing structures with high thermal and acoustic insulation in accordance with the requirements of the region and generating improved habitability and energy savings at a more affordable price.
Patent MX-2008008465-A (MX)
Title: Restrained breast plates, vehicle armored plates and helmets.
Inventor: BHATNAGAR ASHOK
IPC: B29C70/18
Filed: 2006-12-08
Abstract: Ballistic resistiint fabric laminates are provided. More particularly, reinforced, delamination resistant, ballistic resistant composites are provided. The delamination resistant, ballistic resistant materials and articles may be reinforced by various techniques, including stitching one or more ballistic resistant panels with a high strength thread, melting the edges of a ballistic resistant panel to reinforce areas that may have been frayed during standard trimming procedures, wrapping one or more panels with one or more woven or non- woven fibrous wraps, and combinations of these techniques. The delamination resistant, ballistic resistant pane Is may further include at least one rigid plate attached thereto for improving ballistic resistance performance.
Patent MX-2008012969-A (MX)
Title: Polyolefin compositions, articles made therefrom and methods for preparing the same.
Inventor: TURNER MICHAEL D
IPC: C08L23/04
Filed: 2007-04-03
Abstract: The invention provides compositions for blow molding applications and other applications, where such compositions comprise a high molecular weight ethylene interpolymer and a low molecular weight ethylene polymer, and where the high molecular weight ethylene interpolymer has a density from 0.920 g/cm3 </sup>to 0.950 g/cm3</sup>, and an I<sub>2I </sub>from 0.05 to 1 dg/min, and where the low molecular weight ethylene polymer has density from 0.965 g/cm3to 0.985 g/cm3</sup>, and an I<sub>2</sub> from 600 to 2000 dg/min. The composition has a density from 0.950 g/cm3to 0.970 g/cm3</sup>, and comprises greater from 45 to 80 weight percent of the high molecular component, and from 20 to 55 weight percent of the low molecular weight component, based on the sum weight of the high molecular weight component and the low molecular weight component. The invention also provides for methods of preparing said compositions and for articles prepared from the same.
Patent MX-2008013622-A (MX)
Title: Coreless roll product adapter for recessed dispensers.
Inventor: PHELPS STEPHEN L
IPC: A47K10/32
Filed: 2007-03-12
Abstract: An adapter (10) for dispensing coreless or solid rolled product from an existing recessed roll product dispenser (90) is disclosed. The adapter (10) also allows for rolled product to be dispensed from the existing recessed dispenser (90) where the rolls being dispensed may have a larger diameter than allowed by the recessed dispenser without the adapter. A system for dispensing coreless or solid rolled product from an existing recessed dispenser is also disclosed.
Patent MX-2008014060-A (MX)
Title: In-situ measurement of phyisical parameters.
Inventor: HUSHEER SHAMUS
IPC: A61B10/00
Filed: 2007-05-04
Abstract: A data logger device for in-situ measurement of one or more physical parameters comprising a power source; one or more sensors for measuring the one or more physical parameters; a data store for storing representations of at least some of the measured values of the one or more physical parameters; control logic arranged to write the representations of at least some of the measured values to the data store and arranged to read data from the data store during data transmission; an antenna; and a transmitter coupled to the antenna and configured to transmit the stored data by passive transmission.
Patent MX-2008014841-A (MX)
Title: Melatonin agonist treatment.
Inventor: POLYMEROPOULOS MIHAEL H
IPC: A61K31/405
Filed: 2007-05-22
Abstract: This invention provides methods of administering (1 R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]p ropanamide as a melatonin receptor agonist to a human subject to treat or prevent a circadian rhythm disorder or sleep disorder.
Patent MX-2009004638-A (MX)
Title: Methods of generating phosphorus fertilizers through the utilization of microbial fermentation technology.
Inventor: GRECH NIGEL
IPC: C05F11/08
Filed: 2007-11-02
Abstract: This invention includes uses and methods of preparing phosphites and/or hypophosphites (and their polymeric forms and/or their salts) and phosphite-based agrochemicals (fertilizers and biocides) from phosphate or other naturally occurring or synthetic phosphorus sources using anaerobic microbial fermentation. The fermentation process produces both a liquid and solid phase phosphite/hypophosphite salts which can be used as an agrochemical product.
Patent MX-2009006719-A (MX)
Title: Devices and methods for delivering active agents to target sites.
Inventor: RUCINSKI PAUL J
IPC: A61M3/02
Filed: 2007-12-19
Abstract: The subject invention provides novel, inexpensive, and highly effective methods and devices for convenient and effective wound irrigation. In one embodiment the subject invention provides a discharge means for a reservoir housing containing irrigation solution wherein the discharge means has one or more specifically designed nozzles through which a sufficient volume of the irrigation solution can pass at an appropriate pressure.
Patent MX-2009007099-A (MX)
Title: Resource restricted allocation in long-term evolution.
Inventor: FREDERIKSEN FRANK
IPC: H04L12/56
Filed: 2007-12-28
Abstract: A method, user equipment, network device, and software product enable allocation of a number of resource blocks over a downlink to the user equipment. The resource blocks are grouped into a number of groups of the blocks, the number of groups being no greater than a maximum number. The resource blocks are arranged in an adjacent manner within each of the groups. The resource blocks are allocated by operating on the groups, and the allocation is signalled using a group allocation indication.
Patent MX-2009008872-A (MX)
Title: Macrocyclic compounds as hcv ns3 protease inhibitors.
Inventor: EHRHARDT CLAUS
IPC: C07D519/00
Filed: 2008-02-19
Abstract: The present application describes macrocyclic compounds of formula (I) with NS3 protease inhibitory activity for treating hepatitis C virus infection.
Patent MX-2009011118-A (MX)
Title: Heating systems for heating subsurface formations.
Inventor: VINEGAR HAROLD J
IPC: E21B36/02
Filed: 2008-04-18
Abstract: Methods and systems for heating a subsurface formation are described herein. A heating system for a subsurface formation includes a sealed conduit positioned in an opening in the formation and a heat source. The sealed conduit includes a heat transfer fluid. The heat source provides heat to a portion of the sealed conduit to change phase of the heat transfer fluid from a liquid to a vapor. The vapor in the sealed conduit rises in the sealed conduit, condenses to transfer heat to the formation and returns to the conduit portion as a liquid.
Patent MX-2009012077-A (MX)
Title: Organic compounds.
Inventor: FAIRHURST ROBIN ALEC
IPC: A61P11/00
Filed: 2008-05-05
Abstract: A compound of formula (I), or tautomers, or stereoisomers, or solvates, or pharmaceutically acceptable salts thereof, wherein M1, M2, L1, L2, W1, W2, X1, X2, Y1, Y2, A, R5 and R5a are as defined herein for the for treatment of conditions treatable by the blockade of an epithelial sodium channel, particularly conditions benefiting from mucosal hydration.
Patent MX-2010001322-A (MX)
Title: Portable urinal comprising a ho.
Inventor: JORGE E VELASCO M
IPC: A47K11/00
Filed: 2008-08-01
Abstract: The invention relates to a hygienic urinal intended for use by people on farms, at large events and, in particular, at the top, or between the floors of a structure under construction. For this purpose, the invention comprises a portable urinal with a wash-hand basin, formed by a hollow prism having a rectangular base and a U-shaped concave urinal projecting out from the front surface thereof. The upper part of the rear face of the concave urinal is communicated with an upper oval wash-hand basin by means of multiple holes, thereby enabling a curtain of water to flow into the prism through small lower holes. The upper inner part of the prism is provided with a drinking water tank which is connected via a hose to a foot pump located in a cavity at the bottom right corner, such that, when necessary, the user can use the foot pump to activate the discharge of water through a curved faucet above the wash-hand basin. Subsequently, a curtain of water flows through multiple perforations provided in the upper part of the concave urinal and on into the prism. In this way, the prism is filled and once it has been totally or partially filled the contents are emptied through a ball cock located on the lower rear part of the prism or are drawn through a trap door or side cover. The base of the urinal is fitted with four wheels so that it can be easily moved. In addition, two side screens and a rear screen can be fitted on the upper periphery of the prism to ensure privacy. Furthermore, the invention includes an optional removable roof which can be mounted on the screens.
Patent MX-2010003060-A (MX)
Title: Inhibitors of the interaction between mdm2 and p53.
Inventor: COUPA SOPHIE
IPC: A61P35/00
Filed: 2008-09-18
Abstract: The present invention provides compounds of formula (I), their use as an inhibitor of a p53-MDM2 interaction as well as pharmaceutical compositions comprising said compounds; wherein n, m, p, s, t, R<sup>1</sup>, R<sup>2</sup>, R<sup>3</sup>, R<sup>4</sup>, R<sup>5</sup>, R<sup>6</sup>, R<sup>7</sup>, R<sup>20</sup>, X, Y, Q and Z have defined meanings.
Patent MX-2010004971-A (MX)
Title: Methods of identifying safe nmda receptor antagonists.
Inventor: LIOTTA DENNIS C
IPC: G01N31/22
Filed: 2008-11-06
Abstract: Processes are providedfor the identifcation a compound that is useful to treat or prevent a disorder that lowers the pH in a region of affected tissue comprising assessing the difference in potency, or potency boost, of the compound at physiological pH versus disorder-induced pH in a cell that expresses a human NMDA receptor. The assessment of potency boost can include measuring an IC50 of a compound at physiological pH and at disorder-induced pH (the "potency boost") until a 95% confidence interval for the potency boost does not change more than 15% with the addition of a new experiment, wherein the measurements are repeated at least 5 times. The processes can be used for the selection of safe NMDA receptor antagonists for the treatment or prevention of a human disorder that lowers the pH in a region of affected tissue. Such disorders include, but are not limited to, neuropathic pain, ischemia, Parkinsons disease, epilepsy and traumatic brain injuries.
Patent MX-2010005477-A (MX)
Title: Article comprising fibers and a method of forming the same.
Inventor: CLARK ANETA
IPC: D04H1/42
Filed: 2008-11-20
Abstract: An article is provided that comprises fibers, as is a method of forming the article. The fibers comprise an organopolysiloxane component selected from (i) an organopolysiloxane having the formula (R3SiOi/2)w(R2SiÎ¸2/2)Ï(RSiÎ¸3/2)y(SiÎ¸4/2)z (I), wherein each R is selected from the group of an inorganic group, an organic group, and combinations thereof, w is from 0 to 0.95, x is from 0 to 0.95, y is from 0 to 1, z is from 0 to 0.9, and w+x+y+z=l, and (ii) a cured product of said organopolysiloxane having the formula (I), and combinations of (i) and (ii), provided that the fibers are free from organic polymers, organic copolymers, and organosiloxane-organic copolymers. The method of forming the article includes the step of forming fibers from a composition. The composition used to form the fibers comprises the organopolysiloxane having the formula (I), provided that the composition is free from organic polymers, all-organic copolymers, and organosiloxane-organic copolymers. The article exhibits excellent hydrophobicity and maximized fire resistance.
Patent MX-2010008356-A (MX)
Title: Electromagnetic interference suppression sheet comprising pressure-sensitive adhesive layer with structured surface.
Inventor: MITSUI AKIHIKO
IPC: H05K9/00
Filed: 2009-01-27
Abstract: The present invention addresses the prevention of local entrapment of air between an electromagnetic interference suppression sheet attached to an adherend and the adherend, and thereby achieve placement of the electromagnetic interference suppression layer at a constant distance from the adherend surface and obtain a uniform electromagnetic interference suppression effect across the entire attachment surface. There is provided an electromagnetic interference suppression sheet comprising an electromagnetic interference suppression layer that contains a soft magnetic powder and an organic binder, and a pressure-sensitive adhesive layer having a structured surface with the side opposite the structured surface being laminated in contact with the electromagnetic interference suppression layer, wherein a continuous groove reaching to the outer perimeter of the pressure-sensitive adhesive layer is formed in the structured surface.
Patent MX-2010008743-A (MX)
Title: Heat treatment of helical springs or similarly shaped articles by electric resistance heating.
Inventor: WARNER JERRY G
IPC: F16F1/06
Filed: 2010-08-09
Abstract: Apparatus and method are provided for metallurgical heat treatment of coil springs, or similarly shaped workpieces and articles of manufacture, by electric resistance heating along the entire length of the workpiece so that the ends of the workpiece can be heat treated to the same degree and quality as the section of the workpiece between its two ends.
Patent MX-2010010402-A (MX)
Title: Ocular imaging.
Inventor: HARTUNG PAUL
IPC: A61B3/117
Filed: 2009-03-27
Abstract: A system for performing at least one of quasi-elastic light scattering and fluorescent ligand scanning on a subject's eye includes a light source configured to transmit light toward the subject's eye, a lens configured to focus light sent from the source and received from the subject's eye, a measurement reflector disposed to receive at least a portion of the focused light and configured to reflect a first portion of the received light, a camera configured and disposed to receive the first portion of the received light and configured to provide indicia of an image corresponding to the first portion of the received light, and a processor coupled to the camera and configured to analyze intensities of light in the image to determine a location of a reference point corresponding to an interface of a portion of the eye.
Patent MX-2010010743-A (MX)
Title: Oxytocin analogues.
Inventor: SCHTEINGART CLAUDIO
IPC: A61K38/095
Filed: 2009-03-30
Abstract: The present invention relates to novel compounds, pharmaceutical compositions comprising the same, use of said compounds for the manufacture of a medicament for treatment of inter alia compromised lactation conditions as well as to a method for treatment of said conditions, wherein said compounds are administered. The compounds are represented by the general formula (I), as further defined in the specification.
Patent MX-2010011603-A (MX)
Title: Tetrazole compounds for reducing uric acid.
Inventor: SHARMA SHALINI
IPC: A61K31/41
Filed: 2009-04-30
Abstract: Uric acid in mammalian subjects is reduced and excretion of uric acid is increased by administering a compound of Formula I. The uric acid-lowering effects of the compounds of this invention are used to treat or prevent a variety of conditions including gout, hyperuricemia, elevated levels of uric acid that do not meet the levels customarily justifying a diagnosis of hyperuricemia, renal dysfunction, kidney stones, cardiovascular disease, risk for developing cardiovascular disease, tumor-lysis syndrome, cognitive impairment, early-onset essential hypertension, and Plasmodium falciparum-induced inflammation. In Formula 1, x is 1 or 2: y is O, 1, 2 or 3; and R<sup>1</sup> is selected from the group consisting of hydrogen, alkyl having 1 or 2 carbon atoms, hydroxy, alkoxy having 1 or 2 carbon atoms, fluoro. chloro, bromo, and amino. A is phenyl unsubstituted or substituted by one, two or three groups selected from the group consisting of halo, alkyl having 1 or 2 carbon atoms. perfluoromethyL alkoxy having 1 or 2 carbon atoms, and perfluoromethoxy; or cycloalkyl having from 3 to 6 ring atoms wherein the cycloalky! is unsubstituted or one one two ring carbons are independently mono-substituted by methyl or ethyl; or a 5 or 6 membered heleraromatic ring having 1 or 2 ring heteroatoms selected from N. S and O and the heteroaromatic ring is covalently bound to the remainder of the compound by a ring carbon.